Ram Mukunda - 17 Oct 2025 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
CEO, Director
Signature
/s/ Ram Mukunda
Issuer symbol
IGC
Transactions as of
17 Oct 2025
Net transactions value
$0
Form type
4
Filing time
20 Oct 2025, 20:10:14 UTC
Previous filing
15 May 2025
Next filing
04 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mukunda Ram CEO, Director 10224 FALLS ROAD, POTOMAC /s/ Ram Mukunda 17 Oct 2025 0001047575

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGC Common Stock Gift $0 -100,000 -2.4% $0.000000 3,992,678 17 Oct 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC Options Award $0 +3,000,000 $0.000000 3,000,000 17 Oct 2025 Common Stock 3,000,000 Direct F1
transaction IGC Options Award $0 +1,500,000 $0.000000 1,500,000 17 Oct 2025 Common Stock 1,500,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted options exercisable at $0.35, vesting equally over the next three years starting on March 31, 2026.
F2 The Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest when milestones are achieved. The exercise price is $0.35.
F3 Gift of shares of the Company's common stock to the reporting person's children who do not share the reporting person's household.